本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

27.61
+1.646.31%
成交量:353.07万
成交额:9,519.89万
市值:40.31亿
市盈率:-15.16
高:27.72
开:25.96
低:25.88
收:25.97
52周最高:27.72
52周最低:9.60
股本:1.46亿
流通股本:9,712.58万
量比:1.23
换手率:3.64%
股息:- -
股息率:- -
每股收益(TTM):-1.8212
每股收益(LYR):-2.0595
净资产收益率:-60.62%
总资产收益率:-25.26%
市净率:13.37
市盈率(LYR):-13.41

数据加载中...

2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/12

重要事件披露

Form 8-K - Current report
2025/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities